Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

José Rodrigues Pereira; Rebecca Cheng; Mauro Orlando; Joo-Hang Kim; Helen Barraclough

首页> 外文期刊>Drugs in R&D >Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

【24h】

Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Many physicians consider platinum-doublet chemotherapy inappropriate for elderly patients, regardless of their medical fitness.

机译：背景技术许多医生认为，铂金双联化疗不适合老年患者，而不论他们的身体状况如何。

著录项

来源
《Drugs in R&D》 |2013年第4期|289-296|共8页
作者
José Rodrigues Pereira; Rebecca Cheng; Mauro Orlando; Joo-Hang Kim; Helen Barraclough;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Elderly Subset Analysis of Randomized Phase?III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [J] . José Rodrigues Pereira, Rebecca Cheng, Mauro Orlando, Drugs in R&D . 2013,第4期

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析
2. A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/carboplatin as first-line treatment for advanced, nonsquamous non-small cell lung cancer. [J] . Rodrigues Pereira J, Kim JH, Magallanes M, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2011,第11期

机译：一项比较培美曲塞/卡铂和多西他赛/卡铂作为晚期非鳞状非小细胞肺癌一线治疗的随机3期试验。
3. Randomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage IIIB/IV non-small cell lung cancer. [J] . Socinski MA, Raju RN, Stinchcombe T, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2010,第12期

机译：培美曲塞和卡铂联合或不联合enzastaurin与多西他赛和卡铂作为IIB / IV期非小细胞肺癌患者的一线治疗的随机II期试验。
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Long-term smoking-mediated downregulation of Smad3 induces tumorigenicity and carboplatin resistance in non-small cell lung cancer [D] . Samanta, Debangshu. 2012

机译：长期吸烟介导的Smad3的下调诱导非小细胞肺癌的致瘤性和卡铂耐药性
6. Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [O] . José Rodrigues Pereira, Rebecca Cheng, Mauro Orlando, -1

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析
7. Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [O] . 2013

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析

Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

摘要

著录项

相似文献

相关主题

期刊订阅